Methylamine → HCID 21104328, compound
Reaction equation
[Cl:1][C:2]1[CH:3]=[CH:4][C:5]([F:28])=[C:6]([C:8]2[N:13]=[C:12]([NH:14][C:15]3[C:20]([C:21](O)=[O:22])=[CH:19][N:18]=[CH:17][CH:16]=3)[C:11]3[CH:24]([CH3:27])[CH2:25][CH2:26][C:10]=3[N:9]=2)[CH:7]=1.[CH2:29]([N:31](CC)CC)C.CN.C1CN([P+](ON2N=NC3C=CC=CC2=3)(N2CCCC2)N2CCCC2)CC1.F[P-](F)(F)(F)(F)F>CN(C=O)C>[Cl:1][C:2]1[CH:3]=[CH:4][C:5]([F:28])=[C:6]([C:8]2[N:13]=[C:12]([NH:14][C:15]3[C:20]([C:21]([NH:31][CH3:29])=[O:22])=[CH:19][N:18]=[CH:17][CH:16]=3)[C:11]3[CH:24]([CH3:27])[CH2:25][CH2:26][C:10]=3[N:9]=2)[CH:7]=1Participants
Reactant 4
Product 1
Reagents, catalysts & solvents 1
Procedure
To a suspension of 4-[2-(5-chloro-2-fluorophenyl)-5-methyl-6,7-dihydro-5H-cyclopentapyrimidin-4-ylamino]-nicotinic acid (20 mg, 0.05 mmol, 1 eq) in DMF (2 ml) was added triethylamine (8 μl, 0.05 mmol, 1.1 eq) followed by methylamine (250 μl, 3.89 mmol, 2M solution in THF, 10 eq). To the suspension was added a solution of PyBOP (40 mg, 0.08 mmol, 1.5 eq) in DMF (1 ml) dropwise. The reaction mixture was stirred at room temperature for 16 h. The reaction was concentrated in vacuo and the residue was triturated with ether (2×20 ml). The crude residue was purified by flash column chromatography (100% ethylacetate) to afford 4-[2-(5-chloro-2-fluorophenyl)-5-methyl-6,7-dihydro-5H-cyclopentapyrimidin-4-ylamino]-N-methyl-nicotinamide, 47 (12 mg, 58%) as a white solid.
Workup
- concentrationThe reaction was concentrated in vacuo
- customthe residue was triturated with ether (2×20 ml)
- customThe crude residue was purified by flash column chromatography (100% ethylacetate)
Sources & evidence
- ORD record
- ord-3ceb14f131b6448d833752a1622a7802
- Source dataset
- uspto-grants-2007_05
- Patent number
- US07223766B2
Reaction notes
Loading…